首页> 外文期刊>Journal of Breast Cancer >Protocatechuic Aldehyde Represses Proliferation and Migration of Breast Cancer Cells through Targeting C-terminal Binding Protein 1
【24h】

Protocatechuic Aldehyde Represses Proliferation and Migration of Breast Cancer Cells through Targeting C-terminal Binding Protein 1

机译:Protocatechuic醛通过靶向C末端结合蛋白1压制乳腺癌细胞的增殖和迁移

获取原文
           

摘要

Purpose C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor that is overexpressed in many cancers. CtBP1 transcriptionally represses a broad array of tumor suppressors, which promotes cancer cell proliferation, migration, invasion, and resistance to apoptosis. Recent studies have demonstrated that CtBP1 is a potential target for cancer therapy. This study was designed to screen for compounds that potentially target CtBP1. Methods Using a structure-based virtual screening for CtBP1 inhibitors, we found protocatechuic aldehyde (PA), a natural compound found in the root of a traditional Chinese herb, Salvia miltiorrhiza , that directly binds to CtBP1. Microscale thermophoresis assay was performed to determine whether PA and CtBP1 directly bind to each other. Further, clustered regularly interspaced short palindromic repeats associated Cas9 nuclease-mediated CtBP1 knockout in breast cancer cells was used to validate the CtBP1 targeting specificity of PA. Results Functional studies showed that PA repressed the proliferation and migration of breast cancer cells. Furthermore, PA elevated the expression of the downstream targets of CtBP1, p21 and E-cadherin, and decreased CtBP1 binding affinity for the promoter regions of p21 and E-cadherin in breast cancer cells. However, PA did not affect the expression of p21 and E-cadherin in the CtBP1 knockout breast cancer cells. In addition, the CtBP1 knockout breast cancer cells showed resistance to PA-induced repression of proliferation and migration. Conclusion Our findings demonstrated that PA directly bound to CtBP1 and inhibited the growth and migration of breast cancer cells through CtBP1 inhibition. Structural modifications of PA are further required to enhance its binding affinity and selectivity for CtBP1.
机译:目的,C末端结合蛋白1(CTBP1)是在许多癌症中过表达的转录抑制剂。 CTBP1转录抑制广泛的肿瘤抑制剂,促进癌细胞增殖,迁移,侵袭和对凋亡的抗性。最近的研究表明CTBP1是癌症治疗的潜在目标。本研究设计用于筛选可能靶向CTBP1的化合物。方法采用基于结构的虚拟筛选的CTBP1抑制剂,我们发现了Protocatechuic醛(PA),一种在传统中草药,丹参的根茎中发现的天然化合物,直接与CTBP1结合。进行微观致热疗法测定以确定PA和CTBP1是否直接均匀均匀。此外,乳腺癌细胞中聚类定期间隙的短语重复相关的Cas9核酸酶介导的CTBP1敲除用于验证PA的靶向特异性的CTBP1。结果功能研究表明,PA压抑了乳腺癌细胞的增殖和迁移。此外,PA升高了CTBP1,P21和E-CDHERIN的下游靶的表达,并降低了P21的启动子区域和乳腺癌细胞中的E-CDERIN蛋白的CTBP1结合亲和力。然而,PA不影响CTBP1敲除乳腺癌细胞中p21和e-cadherin的表达。此外,CTBP1敲除乳腺癌细胞显示出对PA诱导的增殖和迁移的抑制性的抗性。结论我们的研究结果表明,PA直接与CTBP1结合并抑制乳腺癌细胞通过CTBP1抑制的生长和迁移。进一步需要PA的结构修饰,以增强其CTBP1的结合亲和力和选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号